Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686

Diabetes Care

Volumn 39, Issue 1, 2016, Pages e18-

  Dhatariya, Ketan ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CANAGLIFLOZIN; GLUCOSE; ANTIDIABETIC AGENT;

ARTERIAL GAS; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; COHORT ANALYSIS; DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; KETONURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRACTICE GUIDELINE; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; FEMALE; MALE;

CANAGLIFLOZIN; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84962062347     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1956     Document Type: Note

References (3)

1. Erondu N, Desai M, Ways K, Meininger G. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care 2015;38:1680-1686
2. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335-1343
3. Dhatariya K, Savage M, Kelly T, et al.; Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. Second edition [Internet], September 2013. Available from http://www.diabetologists-abcd .org.uk/JBDS/JBDS-IP-DKA-Adults-Revised.pdf. Accessed 19 October 2015